Safety, Pharmacokinetics, Immunogenicity, and Biodistribution of 186Re-Labeled Humanized Monoclonal Antibody BIWA 4 (Bivatuzumab( in Patients with Early-Stage Breast Cancer.
| Autor: | Manuel Koppe1, Frank van Schaijk2, Jan Roos3, Paul van Leeuwen1, Karl-Heinz Heider4, Hartmut Kuthan5, Robert Bleichrodt1 |
|---|---|
| Zdroj: | Cancer Biotherapy & Radiopharmaceuticals. Dec2004, Vol. 19 Issue 6, p720-729. 10p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|